Bruush Oral Care Inc. (BRSH)
Key Statistics
| Latest Price | $0.09 |
|---|---|
| Market Cap | $8.68M |
| Price Change ($) | $- |
| Price Change (%) | 0.00% |
| Volume | 27.07M |
| Shares Outstanding | 100.97M |
| P/E Ratio | -0.01 |
| EPS | $-14.67 |
BRSH Chart
Description
Bruush Oral Care Inc., an oral care company, manufactures and sells electric toothbrushes in the United States and Canada. It offers electric toothbrush kit consisting of three brush heads, a magnetic charging stand and USB power adapter, and a travel case; brush head refills; and accessories. The company sells its products through its website www.bruush.com and various third-party retailers. Bruush Oral Care Inc. was incorporated in 2017 and is headquartered in Toronto, Canada.
About
CEO: Mr. Aneil Singh Manhas
Exchange: NASDAQ
Sector: Consumer Defensive
Industry: Household & Personal Products
Employees: -0.00B
Address: 30 Wellington Street West, Toronto, ON, CA
Website: Bruush Oral Care Inc.
BRSH News
7 ‘Lottery Ticket Stocks' That Could Turn $1K into $10K
Profiting from high-risk, high-reward stocks is a feat easier said than done. Luck can often make a big difference between a total loss and stumbling upon an unforeseen windfall.
investorplace.com
Read More
Brüush Receives Additional Delisting Notification to Address at Hearing
VANCOUVER, BC / ACCESSWIRE / April 19, 2024 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market, LLC ("Nasdaq") on April 15, 2024 notifying the Company that because it is not compliant with Nasdaq's audit committee requirements as set forth in Listing Rule 5605 (the "Audit Committee Requirements"), this deficiency serves as an additional basis for delisting the Company's securities from Nasdaq. This deficiency will be considered by the Hearings Panel (the "Panel") at a hearing that has been scheduled for April 25, 2024 (the "Hearing") to address the Company's other current deficiencies.
accesswire.com
Read More
Brüush Receives Nasdaq Delisting Notification and Files to Appeal
VANCOUVER, BC / ACCESSWIRE / March 1, 2024 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it has received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market, LLC ("Nasdaq") on February 27, 2024 notifying the Company of Nasdaq's determination to delist the Company's common shares from The Nasdaq Capital Market because the Company's common shares had a closing bid price of $0.10 or less for ten consecutive trading days as of February 26, 2024, which triggered a notice of delisting pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(iii) (the "Low Priced Stocks Rule"). In addition to the Low Priced Stocks Rule delisting notice, as previously reported, the Company also currently fails to satisfy the requirement that the closing bid price of its common shares remain at $1.00 or higher, as required by Nasdaq Listing Rule 5550(a)(2), and had received a notice from Nasdaq in that regard on November 15, 2023.
accesswire.com
Read More
Arrive Partners With AllMart Marketplace to Launch Its Smart Mailbox Solution in Antigua
Autonomous Delivery Testing Expected to Follow in Second Half of 2024 INDIANAPOLIS, IN, Feb. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Arrive Technology Inc. ("Arrive"), a technology company focused on facilitating the last inch of the last-mile for autonomous delivery, announced today that it has signed an agreement with AllMart Marketplace (“AllMart”) to initially deploy up to 25 Arrive smart mailboxes to facilitate secure deliveries on the island nation of Antigua. This announcement comes on the heels of Arrive's previously announced agreement and plan of merger with Bruush Oral Care Inc. (Nasdaq: BRSH) (“Brüush”).
globenewswire.com
Read More
Arrive Partners with AllMart Marketplace to Launch its Smart Mailbox Solution in Antigua
Autonomous delivery testing expected to follow in second half of 2024 VANCOUVER, BC and INDIANAPOLIS, IN / ACCESSWIRE / February 8, 2024 / Bruush Oral Care Inc. (NASDAQ:BRSH) ("Brüush") announced today that its pending merger partner, Arrive Technology Inc. ("Arrive"), a technology company focused on facilitating the last inch of the last-mile for autonomous delivery, has signed an agreement with AllMart Marketplace ("AllMart") to initially deploy up to 25 Arrive smart mailboxes to facilitate secure deliveries on the island nation of Antigua. AllMart, an online retailer currently making approximately 120,000 deliveries per year to consumers in Antigua will offer customers, by the month of May, the option for ‘secure delivery' in addition to the current choices of ‘leave it at my door' or ‘hand it to me'.
accesswire.com
Read More
Arrive Acquires AirBox Technologies in Advance of Brüush Merger
Acquisition Broadens Patent Portfolio and Propels Arrive's Smart Mailbox as a Service Capabilities VANCOUVER, BC and INDIANAPOLIS, IN / ACCESSWIRE / December 18, 2023 / Bruush Oral Care Inc. (Nasdaq:BRSH) ("Brüush") announced today that its pending merger partner, Arrive Technology Inc. ("Arrive"), a technology company focused on facilitating the last inch of the last-mile for autonomous delivery, has acquired AirBox Technologies ("AirBox"). This acquisition includes AirBox's patent portfolio, which Arrive believes will broaden the capabilities of its high-tech mailbox system designed for autonomous and conventional package delivery.
accesswire.com
Read More
BRSH Stock Pops 40% as Brüush Ties Up With Arrive in All-Stock Merger
Brüush Oral Care (NASDAQ: BRSH ) stock is up by about 40% today. The company announced that it has entered into an agreement to merge with Arrive.
investorplace.com
Read More
Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger
VANCOUVER, BC and INDIANAPOLIS, IN / ACCESSWIRE / December 15, 2023 / Bruush Oral Care Inc. (Nasdaq:BRSH) ("Brüush") and Arrive Technology Inc. ("Arrive"), a technology company focused on facilitating the last inch of the last-mile for autonomous delivery, today announced they have entered into an agreement and plan of merger. The combined company ("Combined Company") will focus on the advancement and implementation of Arrive's smart Mailbox-as-a-Service (MaaS) platform that makes the exchange of goods between people, robots and drones frictionless through the use of artificial intelligence ("AI").
accesswire.com
Read More
Why Is Bruush Oral Care (BRSH) Stock Up 18% Today?
Bruush Oral Care (NASDAQ: BRSH ) stock is climbing higher on Tuesday after the company provided investors with an update on its potential delisting from the Nasdaq Exchange. According to a filing with the Securities and Exchange Commission (SEC), the company believes that it has regained compliance with Nasdaq listing standards.
investorplace.com
Read More
Why Is Bruush Oral Care (BRSH) Stock Up 184% Today?
Bruush Oral Care (NASDAQ: BRSH ) stock is rocketing higher on Monday despite the oral care company getting a delisting notice. After markets closed on Friday, the company announced it had received a delisting notice from the Nasdaq Exchange's Listing Qualifications Department.
investorplace.com
Read More
Brüush Receives Nasdaq Notification Regarding Minimum Bid Requirements
VANCOUVER, BC / ACCESSWIRE / November 17, 2023 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it has received a notice from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") on November 15, 2023 notifying the Company that the Company is currently not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement") because the closing bid price of the Company's common shares was below $1.00 per share for a period of 30 consecutive business days. The notification has no immediate effect on the listing of the Company's common shares, which will continue to trade uninterrupted on Nasdaq under the ticker "BRSH.
accesswire.com
Read More
Top 5 Defensive Stocks Which Could Rescue Your Portfolio This Month - Beyond Meat (NASDAQ:BYND), Bruush Oral Care (NASDAQ:BRSH)
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
benzinga.com
Read More
Brüush Announces Notice from Nasdaq for Continued Listing
VANCOUVER, BC / ACCESSWIRE / October 5, 2023 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it has received a notice from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") on October 2, 2023 that is has been granted an exception for continued listing on the Nasdaq. As previously disclosed, the Company received a letter from the Nasdaq earlier this year notifying the Company that based on the Company's stockholders' equity as reported in the Company's Annual Report on Form 20-F for its fiscal year ended October 31, 2022 filed with the Securities and Exchange Commission on March 10, 2023, the Company did not meet the minimum stockholders' equity requirement ("Minimum Stockholders' Equity Requirement"), or the alternatives of market value of listed securities or net income from continuing operations for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1) (the "Rule").
accesswire.com
Read More
Brüush Announces Pricing of $5.0 Million Private Placement
VANCOUVER, BC / ACCESSWIRE / October 2, 2023 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it has entered into a securities purchase agreement with an institutional investor to raise gross proceeds of approximately $5.0 million through a private placement, before deducting fees to the placement agent and other offering expenses payable by the Company. In connection with the private placement, the Company will issue 79,724 of its common shares, a prefunded common share purchase warrant (the "Prefunded Warrant") to purchase 7,181,146 common shares, and a common share purchase warrant (the "Common Warrant") to purchase 8,350,000 common shares.
accesswire.com
Read More
Why Is Bruush Oral Care (BRSH) Stock Up 70% Today?
Bruush Oral Care (NASDAQ: BRSH ) stock is rising on Thursday after the oral care company announced an update concerning its warrants. According to a filing, Bruush Oral Care has reached an agreement with certain holders of its warrants for them to exercise them.
investorplace.com
Read More
3 Stocks to Buy With 50% of Their Floats Sold Short
For the ultimate contrarian, few market categories exist that induce white-knuckled pressure quite like stocks with high short interest. At its most simplistic level, bullish traders targeting highly shorted securities believe that the underlying volatility has gone too far.
investorplace.com
Read More
Brüush Oral Care Inc. Announces 1-for-25 Reverse Stock Split Effective Pre-Market Opening on August 1, 2023
VANCOUVER, BC / ACCESSWIRE / July 31, 2023 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), a direct-to-consumer leader in the oral care category, announced today that its Board of Directors has approved a 1-for-25 reverse split of its common shares ("Consolidation") primarily to comply with the Nasdaq's minimum bid price requirement. The Consolidation is effective as of the close of business on July 31, 2023 and the Company's common shares and warrants will trade on a post-split basis under the same symbols, BRSH and BRSHW, respectively, commencing with the opening of trading on the Nasdaq on August 1, 2023.
accesswire.com
Read More
Brüush Oral Care Inc. Announces Receipt of Notice from Nasdaq Regarding the Determination of Delisting
VANCOUVER, BC / ACCESSWIRE / July 26, 2023 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it has received a notice ("Notice") from the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market ("Nasdaq") on July 20, 2023. The Notice advised that the Company that its securities will be delisted from Nasdaq in accordance with Listing Rules Listing Rule 5450(a)(1), 5810(c)(3)(A) and 5550(b)(1) (the "Listing Rules").
accesswire.com
Read More
Brüush to Present at the Gravitas 4th Los Angeles Summit
VANCOUVER, BC / ACCESSWIRE / May 31, 2023 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), a direct-to-consumer leader in the oral care category, announced today that Aneil Manhas, Founder & CEO, will be presenting at the Gravitas 4th Los Angles Summit taking place at The Beverly Hills Hotel from Sunday, June 4th to Tuesday, June 6th, 2023, in Beverly Hills, California. Aneil Manhas is scheduled to present on Tuesday, June 6th, 2023, at 1:00 PM PDT.
accesswire.com
Read More
Brüush to Present at the Sequire Investor Summit in Puerto Rico
VANCOUVER, BC / ACCESSWIRE / April 18, 2023 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), a direct-to-consumer leader in the oral care category, announced today that Aneil Manhas, Founder & CEO, will present at the Sequire Investor Summit being held at the La Concha Resort in San Juan, Puerto Rico on April 24-26. Aneil Manhas is scheduled to present on Tuesday, April 25 at 3:30 PM, and will also field investor questions and host individual investor meetings on Tuesday and Wednesday.
accesswire.com
Read More
PARVIS INVEST INC. AND GRAVITAS II CAPITAL CORP.
VANCOUVER, BC , March 2, 2023 /PRNewswire/ - Gravitas II Capital Corp. ("Gravitas II") (TSXV: GII.P) and Parvis Invest Inc. ("Parvis") are pleased to announce that, in connection with their previously announced proposed business combination (the "Transaction") as described in Gravitas II's news releases dated November 3, 2022 and August 29, 2022, the TSX Venture Exchange Inc. (the "Exchange") has conditionally approved the Transaction and the listing of the common shares of Gravitas II, following closing of the Transaction (the "Resulting Issuer"). The Transaction is expected to close on March 3, 2023, following which the common shares of the Resulting Issuer are expected to begin trading under the symbol "PVIS" on or about March 10, 2023.
prnewswire.com
Read More
Brüush to Present at the Benchmark Company's Upcoming Discovery One-on-One Investor Conference
VANCOUVER, BC / ACCESSWIRE / November 29, 2022 / Bruush Oral Care Inc. (NASDAQ:BRSH) ("Brüush"), today announced it will be presenting at the Benchmark Company's 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1st, 2022 at the New York Athletic Club in New York City. Aneil Manhas, Founder & CEO of Brüush, is scheduled to participate in one-on-one meetings with institutional analysts and investors throughout the day.
accesswire.com
Read More
Brüush To Present At Dawson James Securities 7th Annual Small Cap Growth Conference
VANCOUVER, BC / ACCESSWIRE / October 4, 2022 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company") announced today that Aneil Manhas, Founder & CEO, will provide a company overview at the Dawson James Securities Small Cap Growth Conference on October 12, 2022 at the Wyndham Grand Hotel in Jupiter, Florida. To access the live webcast and subsequent archived recordings for the presentation, please visit https://wsw.com/webcast/dawson7/brsh/2034445 or check the Company's website after the conference at https://investors.bruush.com/events for an archived copy.
accesswire.com
Read More
Bruush Oral Care Is Hoping to Take Over Your Bathroom
Direct-to-consumer business models are an interesting approach adopted by many companies in order to increase margins and have a strong sense of consumer loyalty. The process of eliminating wholesalers, distributors and retailers, as well as their share of margins in the value chain, is not easy and requires heavy marketing and branding efforts, especially through online media.
gurufocus.com
Read MoreAnnual Income Statement
| Breakdown | 2022-10-31 | 2021-10-31 | 2021-01-31 | 2020-01-31 |
|---|---|---|---|---|
| Revenue | $2.63M | $2.62M | $901.16K | $207.40K |
| Cost of Revenue | $822.38K | $1.30M | $291.19K | $66.60K |
| Gross Profit | $1.81M | $1.32M | $609.97K | $140.81K |
| Gross Profit Ratio | 68.76% | 50.23% | 67.69% | 67.89% |
| Research and Development Expenses | $96.43K | $- | $- | $6.69K |
| General and Administrative Expenses | $4.64M | $1.61M | $6.23M | $644.83K |
| Selling and Marketing Expenses | $7.25M | $4.46M | $2.68M | $845.62K |
| Selling General and Administrative Expenses | $11.89M | $6.79M | $8.91M | $1.49M |
| Other Expenses | $162.05K | $- | $25.04K | $- |
| Operating Expenses | $12.15M | $6.85M | $8.94M | $1.50M |
| Cost and Expenses | $12.98M | $8.16M | $9.23M | $1.57M |
| Interest Income | $1.16M | $80.24K | $- | $15.41K |
| Interest Expense | $3.84M | $80.24K | $18.13K | $15.41K |
| Depreciation and Amortization | $15.35K | $7.33K | $- | $1.36M |
| EBITDA | $-10.49M | $-5.47M | $-8.33M | $-1.36M |
| EBITDA Ratio | -398.63% | -208.79% | -924.18% | -656.68% |
| Operating Income | $-10.51M | $-5.48M | $-8.33M | $-1.36M |
| Operating Income Ratio | -399.21% | -209.07% | -924.18% | -656.68% |
| Total Other Income Expenses Net | $1.74M | $-136.25K | $-543.93K | $-1.48K |
| Income Before Tax | $-8.77M | $-5.62M | $-8.89M | $-1.38M |
| Income Before Tax Ratio | -332.97% | -214.27% | -986.55% | -664.82% |
| Income Tax Expense | $-5.59M | $- | $- | $-1.35M |
| Net Income | $-3.18M | $-5.62M | $-8.89M | $-1.38M |
| Net Income Ratio | -120.73% | -214.27% | -986.55% | -664.82% |
| EPS | $-16.55 | $-35.76 | $-30.27 | $-4.69 |
| EPS Diluted | $-16.55 | $-35.72 | $-30.27 | $-4.69 |
| Weighted Average Shares Outstanding | 192.04K | 157.00K | 293.75K | 293.75K |
| Weighted Average Shares Outstanding Diluted | 192.04K | 157.18K | 293.75K | 293.75K |
| SEC Filing | Source | Source | Source | Source |
Quarterly Income Statement
| Breakdown | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2022-12-31 | 2022-10-31 | 2022-07-31 | 2022-04-30 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $- | $- | $325.53K | $700.81K | $789.68K | $730.96K | $301.98K | $225.29K | $225.29K | $225.29K | $225.29K | $51.85K | $51.85K | $51.85K | $51.85K |
| Cost of Revenue | $- | $- | $79.34K | $292.19K | $266.56K | $166.84K | $97.83K | $72.80K | $72.80K | $72.80K | $72.80K | $16.65K | $16.65K | $16.65K | $16.65K |
| Gross Profit | $- | $- | $246.20K | $408.62K | $523.12K | $564.11K | $204.15K | $152.49K | $152.49K | $152.49K | $152.49K | $35.20K | $35.20K | $35.20K | $35.20K |
| Gross Profit Ratio | 0.00% | 0.00% | 75.63% | 58.31% | 66.25% | 77.17% | 67.61% | 67.69% | 67.69% | 67.69% | 67.69% | 67.89% | 67.89% | 67.89% | 67.89% |
| Research and Development Expenses | $- | $- | $1.50K | $-0.00B | $96.43K | $- | $24.11K | $- | $- | $- | $- | $- | $- | $- | $- |
| General and Administrative Expenses | $- | $- | $1.19M | $540.05K | $1.79M | $1.25M | $661.88K | $2.23M | $2.23M | $2.23M | $2.23M | $372.61K | $372.61K | $372.61K | $372.61K |
| Selling and Marketing Expenses | $- | $- | $633.10K | $2.50M | $4.24M | $411.52K | $435.86K | $670.41K | $670.41K | $670.41K | $670.41K | $211.40K | $211.40K | $211.40K | $211.40K |
| Selling General and Administrative Expenses | $- | $- | $1.82M | $3.68M | $6.03M | $1.66M | $1.10M | $2.90M | $2.90M | $2.90M | $2.90M | $584.02K | $584.02K | $584.02K | $584.02K |
| Other Expenses | $- | $- | $159.32K | $-41.54K | $175.52K | $20.85K | $-41.54K | $-5.13M | $-5.13M | $-5.13M | $-5.13M | $-959.71K | $-959.71K | $-959.71K | $-959.71K |
| Operating Expenses | $- | $- | $1.84M | $3.09M | $6.21M | $1.69M | $1.13M | $-2.23M | $-2.23M | $-2.23M | $-2.23M | $-375.69K | $-375.69K | $-375.69K | $-375.69K |
| Cost and Expenses | $- | $- | $1.92M | $3.38M | $6.47M | $1.85M | $1.23M | $2.31M | $2.31M | $2.31M | $2.31M | $392.34K | $392.34K | $392.34K | $392.34K |
| Interest Income | $- | $- | $220.18K | $112.17K | $46.05K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Interest Expense | $- | $- | $220.18K | $960.83K | $-46.05K | $380.93K | $1.88M | $4.53K | $4.53K | $4.53K | $4.53K | $3.85K | $3.85K | $3.85K | $3.85K |
| Depreciation and Amortization | $- | $- | $1.06K | $1.05K | $6.83K | $2.87K | $2.79K | $-135.98K | $-135.98K | $-135.98K | $-135.98K | $--0.00B | $--0.00B | $--0.00B | $--0.00B |
| EBITDA | $- | $- | $-1.43M | $-3.27M | $-5.84M | $-1.12M | $-925.43K | $-2.22M | $-2.22M | $-2.22M | $-2.22M | $-340.86K | $-340.86K | $-340.86K | $-340.86K |
| EBITDA Ratio | 0.00% | 0.00% | -439.31% | -466.68% | -739.77% | -153.06% | -306.46% | -984.54% | -984.54% | -984.54% | -984.54% | -657.39% | -657.39% | -657.39% | -657.39% |
| Operating Income | $- | $- | $-1.43M | $-3.27M | $-5.85M | $-1.12M | $-1.23M | $-2.08M | $-2.08M | $-2.08M | $-2.08M | $-340.49K | $-340.49K | $-340.49K | $-340.49K |
| Operating Income Ratio | 0.00% | 0.00% | -439.64% | -466.83% | -740.63% | -153.45% | -407.48% | -924.18% | -924.18% | -924.18% | -924.18% | -656.68% | -656.68% | -656.68% | -656.68% |
| Total Other Income Expenses Net | $- | $- | $1.34M | $479.36K | $5.22M | $-171.22K | $76.37K | $-140.51K | $-140.51K | $-140.51K | $-140.51K | $-4.22K | $-4.22K | $-4.22K | $-4.22K |
| Income Before Tax | $- | $- | $-475.09K | $-2.79M | $-625.95K | $-1.29M | $-2.73M | $-2.22M | $-2.22M | $-2.22M | $-2.22M | $-344.71K | $-344.71K | $-344.71K | $-344.71K |
| Income Before Tax Ratio | 0.00% | 0.00% | -145.94% | -398.43% | -79.27% | -176.88% | -905.02% | -986.55% | -986.55% | -986.55% | -986.55% | -664.82% | -664.82% | -664.82% | -664.82% |
| Income Tax Expense | $- | $- | $379.50K | $960.83K | $-5.18M | $-209.70K | $960.83K | $135.98K | $135.98K | $135.98K | $135.98K | $-0.00B | $-0.00B | $-0.00B | $-0.00B |
| Net Income | $- | $- | $-475.09K | $-2.79M | $4.55M | $-1.08M | $-2.73M | $-2.36M | $-2.36M | $-2.36M | $-2.36M | $-345.09K | $-345.09K | $-345.09K | $-345.09K |
| Net Income Ratio | 0.00% | 0.00% | -145.94% | -398.43% | 576.27% | -148.19% | -905.02% | -1046.91% | -1046.91% | -1046.91% | -1046.91% | -665.53% | -665.53% | -665.53% | -665.53% |
| EPS | $0.00 | $0.00 | $-0.95 | $-6.40 | $13.96 | $-0.18 | $-11.23 | $-0.39 | $-0.39 | $-0.39 | $-0.39 | $-0.05 | $-0.05 | $-0.05 | $-0.05 |
| EPS Diluted | $0.00 | $0.00 | $-0.95 | $-6.40 | $13.96 | $-0.18 | $-11.23 | $-0.39 | $-0.39 | $-0.39 | $-0.39 | $-0.05 | $-0.05 | $-0.05 | $-0.05 |
| Weighted Average Shares Outstanding | - | - | 498.72K | 436.00K | 326.04K | 6.08M | 243.37K | 6.08M | 6.08M | 6.08M | 6.08M | 7.34M | 7.34M | 7.34M | 7.34M |
| Weighted Average Shares Outstanding Diluted | - | - | 498.72K | 436.52K | 326.04K | 6.08M | 243.37K | 6.08M | 6.08M | 6.08M | 6.08M | 7.34M | 7.34M | 7.34M | 7.34M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | 2022-10-31 | 2021-10-31 | 2021-01-31 | 2020-01-31 |
|---|---|---|---|---|
| Cash and Cash Equivalents | $72.92K | $14.53K | $692.65K | $180.65K |
| Short Term Investments | $18.51K | $7.07K | $- | $- |
| Cash and Short Term Investments | $91.43K | $21.60K | $692.65K | $180.65K |
| Net Receivables | $175.26K | $36.73K | $81.16K | $12.97K |
| Inventory | $241.34K | $830.38K | $1.18M | $598.59K |
| Other Current Assets | $677.47K | $142.56K | $118.37K | $3.45K |
| Total Current Assets | $1.19M | $1.03M | $2.07M | $795.66K |
| Property Plant Equipment Net | $5.62K | $7.43K | $3.20K | $- |
| Goodwill | $- | $- | $- | $- |
| Intangible Assets | $- | $11.47K | $- | $- |
| Goodwill and Intangible Assets | $- | $11.47K | $- | $- |
| Long Term Investments | $- | $- | $- | $-301.89K |
| Tax Assets | $- | $- | $- | $- |
| Other Non-Current Assets | $-5.62K | $- | $- | $- |
| Total Non-Current Assets | $5.62K | $18.90K | $3.20K | $-301.89K |
| Other Assets | $--0.00B | $- | $- | $301.89K |
| Total Assets | $1.19M | $1.05M | $2.07M | $795.66K |
| Account Payables | $909.44K | $2.30M | $236.81K | $257.86K |
| Short Term Debt | $- | $27.14K | $17.58K | $433.99K |
| Tax Payables | $- | $- | $- | $- |
| Deferred Revenue | $6.04K | $- | $92.12K | $- |
| Other Current Liabilities | $1.68M | $2.67M | $1.56M | $18.86K |
| Total Current Liabilities | $2.59M | $4.99M | $1.91M | $710.71K |
| Long Term Debt | $- | $- | $- | $- |
| Deferred Revenue Non-Current | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- |
| Other Non-Current Liabilities | $915.48K | $- | $- | $- |
| Total Non-Current Liabilities | $915.48K | $- | $- | $- |
| Other Liabilities | $-915.48K | $- | $- | $- |
| Total Liabilities | $2.59M | $4.99M | $1.91M | $710.71K |
| Preferred Stock | $- | $- | $- | $- |
| Common Stock | $23.85M | $13.28M | $13.26M | $4.30M |
| Retained Earnings | $-26.39M | $-17.62M | $-13.41M | $-4.52M |
| Accumulated Other Comprehensive Income Loss | $1.14M | $400.94K | $308.66K | $301.88K |
| Other Total Stockholders Equity | $- | $- | $- | $-0.00B |
| Total Stockholders Equity | $-1.40M | $-3.94M | $163.14K | $84.96K |
| Total Equity | $-1.40M | $-3.94M | $163.14K | $84.96K |
| Total Liabilities and Stockholders Equity | $1.19M | $1.05M | $2.07M | $795.66K |
| Minority Interest | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $1.19M | $1.05M | $2.07M | $795.66K |
| Total Investments | $18.51K | $7.07K | $- | $-301.89K |
| Total Debt | $- | $27.14K | $17.58K | $433.99K |
| Net Debt | $-72.92K | $12.61K | $-675.07K | $253.34K |
Quarterly Balance Sheet
| Breakdown | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2022-12-31 | 2022-10-31 | 2022-07-31 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $- | $- | $194.32K | $-102.12K | $72.92K | $21.54K | $18.23K | $173.16K | $173.16K | $173.16K | $173.16K | $45.16K | $45.16K | $45.16K | $45.16K |
| Short Term Investments | $- | $- | $10.69K | $204.24K | $18.51K | $- | $4.63K | $- | $- | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $- | $- | $194.32K | $102.12K | $91.43K | $21.54K | $22.86K | $173.16K | $173.16K | $173.16K | $173.16K | $45.16K | $45.16K | $45.16K | $45.16K |
| Net Receivables | $- | $- | $152.60K | $43.81K | $175.26K | $97.81K | $43.81K | $20.29K | $20.29K | $20.29K | $20.29K | $3.24K | $3.24K | $3.24K | $3.24K |
| Inventory | $- | $- | $142.95K | $60.34K | $241.34K | $351.34K | $60.34K | $294.06K | $294.06K | $294.06K | $294.06K | $149.65K | $149.65K | $149.65K | $149.65K |
| Other Current Assets | $- | $- | $395.98K | $169.37K | $677.47K | $59.74K | $169.37K | $29.59K | $29.59K | $29.59K | $29.59K | $-0.00B | $-0.00B | $-0.00B | $-0.00B |
| Total Current Assets | $- | $- | $885.85K | $102.12K | $1.19M | $530.43K | $296.37K | $517.11K | $517.11K | $517.11K | $517.11K | $198.92K | $198.92K | $198.92K | $198.92K |
| Property Plant Equipment Net | $- | $- | $4.91K | $1.40K | $5.62K | $6.60K | $1.40K | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $- | $- | $- | $- |
| Goodwill | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $5.86K | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $5.86K | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $- | $- | $-4.91K | $-103.53K | $-5.62K | $-12.45K | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Non-Current Assets | $- | $- | $4.91K | $-102.12K | $5.62K | $12.45K | $1.40K | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $- | $- | $- | $- |
| Other Assets | $- | $- | $- | $297.78K | $--0.00B | $--0.00B | $-0.00B | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $- | $- | $890.76K | $297.78K | $1.19M | $542.88K | $297.78K | $517.90K | $517.90K | $517.90K | $517.90K | $198.92K | $198.92K | $198.92K | $198.92K |
| Account Payables | $- | $- | $1.66M | $227.36K | $909.44K | $2.45M | $227.36K | $59.20K | $59.20K | $59.20K | $59.20K | $64.47K | $64.47K | $64.47K | $64.47K |
| Short Term Debt | $- | $- | $2.65M | $-0.00B | $- | $29.38K | $-0.00B | $4.39K | $4.39K | $4.39K | $4.39K | $108.50K | $108.50K | $108.50K | $108.50K |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $2.01K | $1.51K | $6.04K | $11.78K | $1.51K | $23.03K | $23.03K | $23.03K | $23.03K | $- | $- | $- | $- |
| Other Current Liabilities | $- | $- | $1.76M | $419.61K | $1.68M | $2.32M | $419.61K | $390.49K | $390.49K | $390.49K | $390.49K | $4.71K | $4.71K | $4.71K | $4.71K |
| Total Current Liabilities | $- | $- | $6.07M | $648.48K | $2.59M | $4.82M | $648.48K | $477.12K | $477.12K | $477.12K | $477.12K | $177.68K | $177.68K | $177.68K | $177.68K |
| Long Term Debt | $- | $- | $- | $- | $- | $4.45M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $- | $- | $- | $228.87K | $915.48K | $- | $228.87K | $86.63K | $86.63K | $86.63K | $86.63K | $172.96K | $172.96K | $172.96K | $172.96K |
| Total Non-Current Liabilities | $- | $- | $- | $228.87K | $915.48K | $4.45M | $228.87K | $86.63K | $86.63K | $86.63K | $86.63K | $172.96K | $172.96K | $172.96K | $172.96K |
| Other Liabilities | $- | $- | $- | $-228.87K | $-915.48K | $- | $-228.87K | $-86.63K | $-86.63K | $-86.63K | $-86.63K | $-172.96K | $-172.96K | $-172.96K | $-172.96K |
| Total Liabilities | $- | $- | $6.07M | $648.48K | $2.59M | $9.26M | $648.48K | $477.12K | $477.12K | $477.12K | $477.12K | $177.68K | $177.68K | $177.68K | $177.68K |
| Preferred Stock | $- | $- | $- | $1.40M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $- | $- | $24.89M | $5.96M | $23.85M | $16.43M | $5.96M | $3.32M | $3.32M | $3.32M | $3.32M | $1.08M | $1.08M | $1.08M | $1.08M |
| Retained Earnings | $- | $- | $-31.97M | $-6.60M | $-26.39M | $-25.76M | $-6.60M | $-3.35M | $-3.35M | $-3.35M | $-3.35M | $-1.13M | $-1.13M | $-1.13M | $-1.13M |
| Accumulated Other Comprehensive Income Loss | $- | $- | $1.91M | $-1.40M | $1.14M | $613.34K | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Total Stockholders Equity | $- | $- | $-0.00B | $-767.64K | $- | $- | $284.45K | $77.17K | $77.17K | $77.17K | $77.17K | $75.47K | $75.47K | $75.47K | $75.47K |
| Total Stockholders Equity | $- | $- | $-5.18M | $-1.40M | $-1.40M | $-8.72M | $-350.70K | $40.78K | $40.78K | $40.78K | $40.78K | $21.24K | $21.24K | $21.24K | $21.24K |
| Total Equity | $- | $- | $-5.18M | $-1.40M | $-1.40M | $-8.72M | $-350.70K | $40.78K | $40.78K | $40.78K | $40.78K | $21.24K | $21.24K | $21.24K | $21.24K |
| Total Liabilities and Stockholders Equity | $- | $- | $890.76K | $-1.40M | $1.19M | $542.88K | $297.78K | $517.90K | $517.90K | $517.90K | $517.90K | $198.92K | $198.92K | $198.92K | $198.92K |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $- | $- | $890.76K | $-1.40M | $1.19M | $542.88K | $297.78K | $517.90K | $517.90K | $517.90K | $517.90K | $198.92K | $198.92K | $198.92K | $198.92K |
| Total Investments | $- | $- | $10.69K | $204.24K | $18.51K | $- | $4.63K | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Debt | $- | $- | $2.65M | $- | $- | $4.48M | $- | $4.39K | $4.39K | $4.39K | $4.39K | $108.50K | $108.50K | $108.50K | $108.50K |
| Net Debt | $- | $- | $2.45M | $102.12K | $-72.92K | $4.46M | $-18.23K | $-168.77K | $-168.77K | $-168.77K | $-168.77K | $63.33K | $63.33K | $63.33K | $63.33K |
Annual Cash Flow Statement
| Breakdown | 2022-10-31 | 2021-10-31 | 2021-01-31 | 2020-01-31 |
|---|---|---|---|---|
| Net Income | $-8.77M | $-5.62K | $-8.89M | $-1.38M |
| Depreciation and Amortization | $15.35K | $-0.00B | $- | $- |
| Deferred Income Tax | $- | $-569.57K | $- | $- |
| Stock Based Compensation | $279.62K | $-0.00B | $4.95M | $-0.00B |
| Change in Working Capital | $-2.13M | $-0.00B | $-636.64K | $-80.70K |
| Accounts Receivables | $-14.21K | $--0.00B | $-68.19K | $-10.19K |
| Inventory | $589.04K | $-0.00B | $-577.66K | $-261.23K |
| Accounts Payables | $-2.02M | $- | $32.00K | $190.69K |
| Other Working Capital | $-681.80K | $-0.00B | $-22.80K | $-0.00B |
| Other Non Cash Items | $-1.99M | $4.09K | $525.28K | $-52.41K |
| Net Cash Provided by Operating Activities | $-12.59M | $--0.00B | $-4.05M | $-1.46M |
| Investments in Property Plant and Equipment | $-2.04K | $--0.00B | $-3.20K | $- |
| Acquisitions Net | $- | $- | $- | $- |
| Purchases of Investments | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- |
| Other Investing Activities | $- | $--0.00B | $- | $- |
| Net Cash Used for Investing Activities | $-2.04K | $--0.00B | $-3.20K | $- |
| Debt Repayment | $-4.88M | $- | $-433.99K | $-77.81K |
| Common Stock Issued | $13.67M | $- | $4.97M | $1.35M |
| Common Stock Repurchased | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- |
| Other Financing Activities | $3.86M | $-0.00B | $28.51K | $301.89K |
| Net Cash Used Provided by Financing Activities | $12.65M | $-0.00B | $4.57M | $1.58M |
| Effect of Forex Changes on Cash | $- | $1.42M | $- | $- |
| Net Change in Cash | $58.39K | $-0.00B | $512.00K | $118.68K |
| Cash at End of Period | $72.92K | $-0.00B | $692.65K | $180.65K |
| Cash at Beginning of Period | $14.53K | $-0.00B | $180.65K | $61.97K |
| Operating Cash Flow | $-12.59M | $--0.00B | $-4.05M | $-1.46M |
| Capital Expenditure | $-2.04K | $--0.00B | $-3.20K | $- |
| Free Cash Flow | $-12.59M | $--0.00B | $-4.06M | $-1.46M |
Quarterly Cash Flow Statement
| Breakdown | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2022-12-31 | 2022-10-31 | 2022-07-31 | 2022-04-30 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $- | $- | $-475.09K | $-2.79M | $-625.95K | $-1.29M | $-2.73M | $-2.22M | $-2.22M | $-2.22M | $-2.22M | $-344.71K | $-344.71K | $-344.71K | $-344.71K |
| Depreciation and Amortization | $- | $- | $1.05K | $1.05K | $6.83K | $2.87K | $2.82K | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Income Tax | $- | $- | $-263.41K | $-0.00B | $- | $-204.89K | $-96.44K | $- | $- | $- | $- | $- | $- | $- | $- |
| Stock Based Compensation | $- | $- | $202.88K | $203.08K | $203.27K | $68.49K | $3.93K | $1.24M | $1.24M | $1.24M | $1.24M | $- | $- | $- | $- |
| Change in Working Capital | $- | $- | $145.45K | $145.45K | $-2.98M | $591.50K | $112.52K | $-159.16K | $-159.16K | $-159.16K | $-159.16K | $-20.17K | $-20.17K | $-20.17K | $-20.17K |
| Accounts Receivables | $- | $- | $11.33K | $11.33K | $-77.44K | $- | $8.98K | $- | $- | $- | $- | $- | $- | $- | $- |
| Inventory | $- | $- | $49.20K | $49.20K | $222.52K | $199.46K | $83.53K | $-144.41K | $-144.41K | $-144.41K | $-144.41K | $-65.31K | $-65.31K | $-65.31K | $-65.31K |
| Accounts Payables | $- | $- | $- | $679.20K | $-2.37M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Working Capital | $- | $- | $84.93K | $84.93K | $-754.50K | $392.04K | $20.01K | $-14.75K | $-14.75K | $-14.75K | $-14.75K | $45.13K | $45.13K | $45.13K | $45.13K |
| Other Non Cash Items | $- | $- | $-2.25M | $69.46K | $-5.35M | $343.66K | $933.48K | $131.32K | $131.32K | $131.32K | $131.32K | $- | $- | $- | $- |
| Net Cash Provided by Operating Activities | $- | $- | $-2.37M | $-2.37M | $-8.74M | $-491.26K | $-1.68M | $-1.01M | $-1.01M | $-1.01M | $-1.01M | $-364.89K | $-364.89K | $-364.89K | $-364.89K |
| Investments in Property Plant and Equipment | $- | $- | $--0.00B | $--0.00B | $- | $--0.00B | $-1.02K | $--0.00B | $--0.00B | $--0.00B | $--0.00B | $- | $- | $- | $- |
| Acquisitions Net | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Purchases of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Investing Activities | $- | $- | $- | $- | $- | $-0.00B | $- | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $- | $- | $- | $- |
| Net Cash Used for Investing Activities | $- | $- | $--0.00B | $--0.00B | $- | $--0.00B | $-1.02K | $--0.00B | $--0.00B | $--0.00B | $--0.00B | $- | $- | $- | $- |
| Debt Repayment | $- | $- | $- | $-1.22M | $-4.88M | $-1.22M | $- | $-108.50K | $-108.50K | $-108.50K | $-108.50K | $-19.45K | $-19.45K | $-19.45K | $-19.45K |
| Common Stock Issued | $- | $- | $- | $- | $13.67M | $- | $- | $1.24M | $1.24M | $1.24M | $1.24M | $338.54K | $338.54K | $338.54K | $338.54K |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $- | $- | $2.43M | $2.43M | $8.79M | $1.32M | $1.88M | $-1.13M | $-1.13M | $-1.13M | $-1.13M | $-319.09K | $-319.09K | $-319.09K | $-319.09K |
| Net Cash Used Provided by Financing Activities | $- | $- | $2.43M | $2.43M | $8.79M | $100.03K | $1.88M | $1.13M | $1.13M | $1.13M | $1.13M | $394.56K | $394.56K | $394.56K | $394.56K |
| Effect of Forex Changes on Cash | $- | $- | $60.70K | $--0.00B | $- | $--0.00B | $- | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $- | $- | $- | $- |
| Net Change in Cash | $- | $- | $121.40K | $-54.69K | $51.38K | $-391.23K | $199.12K | $128.00K | $128.00K | $128.00K | $128.00K | $29.67K | $29.67K | $29.67K | $29.67K |
| Cash at End of Period | $- | $194.32K | $194.32K | $18.23K | $72.92K | $21.54K | $199.12K | $173.16K | $173.16K | $173.16K | $173.16K | $45.16K | $45.16K | $45.16K | $45.16K |
| Cash at Beginning of Period | $- | $194.32K | $72.92K | $72.92K | $21.54K | $412.77K | $- | $45.16K | $45.16K | $45.16K | $45.16K | $15.49K | $15.49K | $15.49K | $15.49K |
| Operating Cash Flow | $- | $- | $-2.37M | $-2.37M | $-8.74M | $-491.26K | $-1.68M | $-1.01M | $-1.01M | $-1.01M | $-1.01M | $-364.89K | $-364.89K | $-364.89K | $-364.89K |
| Capital Expenditure | $- | $- | $--0.00B | $--0.00B | $- | $--0.00B | $-1.02K | $--0.00B | $--0.00B | $--0.00B | $--0.00B | $- | $- | $- | $- |
| Free Cash Flow | $- | $- | $-2.37M | $-2.37M | $-8.74M | $-491.77K | $-1.68M | $-1.01M | $-1.01M | $-1.01M | $-1.01M | $-364.89K | $-364.89K | $-364.89K | $-364.89K |
Coming soon...
Dividend Yield
0.00%
Dividend Payout Ratio
0.00x
Dividend Paid & Capex Coverage Ratio
6165.90x
Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|
Key Metrics
Financial Ratios
| Price to Earnings Ratio | -1.65x |
|---|---|
| Price to Book Ratio | -3.73x |
| Current Ratio | 0.46x |
| Quick Ratio | 0.10x |
| Cash Ratio | 0.03x |
| Debt to Equity | 0.00x |
| Return on Invested Capital | 2.72x |
| Return on Equity | 2.27x |
| Return on Assets | -2.67x |
Key Metrics
| Enterprise Value | $5.16M |
|---|---|
| Revenue Per Share | $13.71 |
| Net Income Per Share | $-16.55 |
| Operating Cash Flow Per Share | $-65.56 |
| Free Cash Flow Per Share | $-65.57 |
| Cash Per Share | $0.48 |
| Gross Profit Margin | 0.69% |
| Operating Profit Margin | -3.99% |
| Net Profit Margin | 2.27% |
Financial Growth
| Revenue Growth | 0.00% |
|---|---|
| Gross Profit Growth | 0.38% |
| EPS Growth | 0.54% |
| EBIT Growth | -0.92% |
| Operating Income Growth | -0.92% |
| Revenue Growth | 0.00% |
| Net Income Growth | 0.43% |
| Dividend Per Share Growth | 0.00% |
| Free Cash Flow Growth | -13942.07% |
Coming soon...
Data provided by IEX Cloud & Financial Modeling Prep
Disclaimer: The content of this website is not to be intended as investment advice. The material is provided for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation or endorsement for any security or strategy, nor does it constitute an offer to provide investment advisory or other services by MLQ. MLQ makes no guarantees regarding the accuracy and completeness of the information expressed in this website. See our full Terms of Service for more information.